Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): The incidence and correlation of a HLXB9 overexpression

Cancer Genetics and Cytogenetics

Volumn 191, Issue 2, 2009, Pages 102-105

  Park, Joonhong ^a   Kim, Myungshin ^a   Lim, Jihyang ^a   Kim, Yonggoo ^a   Han, Kyungja ^a   Lee, Jaewook ^a   Chung, Nak Gyun ^a   Cho, Bin ^a   Kim, Hack Ki ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HLXB9 PROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CHILD; CHROMOSOME 12P; CHROMOSOME 7Q; CHROMOSOME TRANSLOCATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE PROBE; GENETIC ANALYSIS; GENETIC CORRELATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADOLESCENT; BONE MARROW; CHILD; CHILD, PRESCHOOL; CHROMOSOME BANDING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 7; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; METAPHASE; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 65549083912     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.02.007     Document Type: Article

References (11)

1. Bohlander S.K. ETV6: A versatile player in leukemogenesis. Semin Cancer Biol 15 (2005) 162-174
2. Tosi S., Harbott J., Teigler-Schlegel A., Haas O.A., Pirc-Danoewinata H., Harrison C.J., Biondi A., Cazzaniga G., Kempkski H., Scherer S.W., and Kearney L. t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia. Genes Chromosomes Cancer 29 (2000) 325-332
3. Tosi S., Hughes J., Scherer S.W., Nakabayashi K., Harbott J., Haas O.A., Cazzaniga G., Biondi A., Kempski H., and Kearney L. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia. Genes Chromosomes Cancer 38 (2003) 191-200
4. Beverloo H.B., Panagopoulos I., Isaksson M., van Wering E., van Drunen E., de Klein A., Johansson B., and Slater R. Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). Cancer Res 61 (2001) 5374-5377
5. Shaffer L.G., and Tommerup N. ISCN: An International System for Human Cytogenetic Nomenclature (2005), S. Karger, Basel
6. Slater R., Ev D., Kroes W.G., Weghuis D.O., van den Berg E., and Smit E.M. van der Does-van den Berg A, van Wering E, Hählen K, Carroll A, Raimondi S, Beverloo H. t(7;12)(q36;p13) and t(7;12)(q32;p13)-translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia 15 (2001) 915-920
7. Wlodarska I., Starza R.L., Baens M., Dierlamm J., Uyttebroeck A., Selleslag D., Francine A., Mecucci C., Hagemeijer A., Van den Berghe H., and Marynen P. Fluorescence in situ hybridization characterization of new translocations involving TEL(ETV6) in a wide spectrum of hematologic malignancies. Blood 91 (1998) 1399-1406
8. von Bergh A.R.M., van Drunen E., van Wering E.R., van Zutven L.J.C.M., Hainmann I., Lonnerholm G., Meijerink J.P., Pieters R., and Beverloo H.B. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer 45 (2006) 731-739
9. Simmons H., Oseth L., Nguyen P., O'Leary M., Conklin K., and Hirsch B. Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML. Leukemia 16 (2002) 2408-2416
10. Hauer J., Tosi S., Schuster F.R., Harbott J., Kolb H.-J., and Borkhardt A. Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement. Pediatric Blood Cancer 50 (2008) 921-923
11. Magnusson M.K., Meade K.E., Nakamura R., Barret J., and Dunber C.E. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor β-receptor fusion oncogene. Blood 100 (2002) 1088-1091